Announcements Trials
Browse Landscape

Phase

Phase 1 3

Status

Completed 3Not yet recruiting 2Terminated 1

Sponsor Class

INDUSTRY 3OTHER_GOV 1NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 1

Conditions

Neoplasms 1905Breast Neoplasms 1426Carcinoma, Non-Small-Cell Lung 1179Prostatic Neoplasms 740Colorectal Neoplasms 686Neoplasm Metastasis 624Multiple Myeloma 548Melanoma 529Ovarian Neoplasms 456Lung Neoplasms 447Lymphoma, Non-Hodgkin 385Recurrence 374Lymphoma 374Leukemia, Myeloid, Acute 370Pancreatic Neoplasms 358Carcinoma, Renal Cell 339Carcinoma, Hepatocellular 286Stomach Neoplasms 281Leukemia, Lymphocytic, Chronic, B-Cell 268Lymphoma, Follicular 254Head and Neck Neoplasms 246Glioblastoma 220Leukemia 215Small Cell Lung Carcinoma 183Lymphoma, Large B-Cell, Diffuse 183Squamous Cell Carcinoma of Head and Neck 181Urinary Bladder Neoplasms 175Carcinoma 175Uterine Cervical Neoplasms 174Advanced Solid Tumors 161

Interventions

copanlisib 1alisporivir 1Trabectedin 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × INDUSTRY × Hepatic Insufficiency × Clear all
NCT03172884 2021-04-28

Study of Copanlisib in Hepatic or Renal Impairment

Bayer

Phase 1 Completed
30 enrolled 20 charts

Hepatic Insufficiency, Renal Insufficiency

NCT01860326 2016-04-28

Evaluate the Pharmacokinetics, Safety, and Tolerability of Alisporivir in Subjects With Hepatic Impairment Compared to Healthy Subjects

Debiopharm International SA

Phase 1 Completed
32 enrolled
Lymphoid

Lymphoma, Follicular, Hepatic Insufficiency

NCT01273493 2016-02-15

A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic Dysfunction

Janssen Research & Development, LLC

Phase 1 Completed
15 enrolled

Liver Diseases, Neoplasm Metastasis, Hepatic Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡